Promega's OncoMate MSI system cleared by FDA

LabPulse.com staff writers
Jul 29, 2021
2019 05 22 19 44 5254 Dna Red Laser 400

Promega announced that its OncoMate microsatellite instability (MSI) Dx Analysis System has been cleared by the U.S. Food and Drug Administration (FDA) for use in labs in the U.S.

With the FDA clearance, the company said oncologists and pathologists in the U.S. can now access the IVD test that screens for Lynch syndrome in patients with colorectal cancer.

Latest in FDA Clearance
Fda Logo V2 Social
FDA starts one-year pilot program to tackle risks of lab developed oncology tests
July 21, 2023
Alzheimers Phases Amyloid Social
Roche receives FDA clearance for test to accelerate diagnosis of Alzheimer’s
June 29, 2023
Latest in at-home or lab-based STI testing
Sponsored
Latest in at-home or lab-based STI testing
September 28, 2023
Fda Sign Dc Social
FDA greenlights Precision BioLogic chromogenic assay to identify factor IX deficiency
January 5, 2023
Related Stories
2020 04 14 22 00 7772 Business Men Handshake 400
Sarcoma
Stilla and Promega sign comarketing agreement
2019 09 16 18 27 8672 Quality Check Mark 400
COVID-19
Promega SARS-CoV-2 antibody test gets CE Mark
2020 07 20 15 52 6356 Epidemiologist Lab 400
CE mark
Promega to further develop OncoMate MSI assay
Latest in at-home or lab-based STI testing
Sponsor Content
Latest in at-home or lab-based STI testing
More in FDA Clearance
FDA starts one-year pilot program to tackle risks of lab developed oncology tests
The goal is to provide laboratories with information to support development of LDTs for specific cancer biomarkers, to facilitate “better and more consistent” testing and, by extension, “better drug selection and improved care for patients with cancer."
July 21, 2023
Fda Logo V2 Social
Roche receives FDA clearance for test to accelerate diagnosis of Alzheimer’s
The new 510(k) clearance covers two tests that run on Roche’s Elecsys immunoassay system. One of the assays, which measures beta-amyloid, was part of the 510(k) clearance that Roche received last year.
June 29, 2023
Alzheimers Phases Amyloid Social
FDA grants 510(k) clearance, CLIA waiver for BioFire multiplex respiratory panel
The FDA reviewed the BioFire test through a dual 510(k) and CLIA waiver pathway, which was designed to speed bringing accurate IVD tests to CLIA-waived settings.
February 7, 2023
Fda Button Social
FDA greenlights Precision BioLogic chromogenic assay to identify factor IX deficiency
The assay is intended for use by clinical labs to identify factor IX deficiency in human plasma and aid in the management of hemophilia B.
January 5, 2023
Fda Sign Dc Social
Roche nabs FDA clearance for two Alzheimer's disease CSF assays
The assays measure beta Amyloid (1-42) and Phospho Tau (181P) concentrations in cerebrospinal fluid samples from adults age 55 and older.
December 8, 2022
Alzheimers Phases Amyloid Social
HemoSonics obtains FDA clearance for whole-blood hemostasis system, cartridge for POC use
The system leverages medical-grade ultrasound technology to measure the coagulation properties of a whole blood sample.
November 30, 2022
Lab Blood Samples Social (1)
Empatica receives FDA clearance for digital biomarker platform, closes Series B financing
The platform is used to gather and analyze physiological data for clinical trials evaluating new therapeutics. Empatica is collaborating with researchers on digital biomarkers for use as endpoints.
November 23, 2022
Computer Woman Ai Social
DiaSorin congenital CMV direct assay receives FDA 510(k) clearance
The molecular diagnostic test enables direct detection of cytomegalovirus (CMV) DNA in saliva swab and urine specimens from babies 21 days old or younger.
November 9, 2022
Baby Bottle Social
FDA clears Baebies disposable G6PD test
The rapid point-of-care test uses a drop of blood to detect glucose-6-phosphate dehydrogenase (G6PD) deficiency, which causes hemolytic anemia.
November 9, 2022
Hospital Baby Nurse Social
Abbott nabs first FDA EUA for a commercial test kit to detect monkeypox
Abbott Molecular received an EUA for an RT-PCR test intended to detect monkeypox DNA using lesion swab specimens from individuals suspected of monkeypox virus infection.
October 7, 2022
Infectious Diseases Research Social
Boston Cell Standards nabs FDA clearance for IHC test panel to evaluate breast cancers
Boston Cell Standards on Thursday announced that the FDA has granted 510(k) clearance for the company’s IHControls panel for evaluating breast cancers.
October 6, 2022
Breast Cancer
Roche nabs FDA clearance for low- to mid-volume lab system
A member of the Cobas family of serum-work-area solutions, the system combines clinical chemistry, immunoassay, and ion-selective electrode diagnostic testing onto a single platform to optimize space and resources for low- to mid-volume labs. It automates manual tasks, improves productivity, and supports fast delivery of patient results, Roche said.
September 18, 2022
2022 09 19 20 10 3970 20191120 Roche Pure Links 5 Us 400
Page 1 of 5
Next Page